Pendal Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $86M | Buy |
297,723
+425
| +0.1% | +$123K | 0.74% | 48 |
|
|
2022
Q3 | $86.1M | Sell |
297,298
-61,498
| -17% | -$17.8M | 0.84% | 41 |
|
|
2022
Q2 | $101M | Buy |
358,796
+356,424
| +15,026% | +$100M | 0.99% | 38 |
|
|
2022
Q1 | $619K | Sell |
2,372
-12
| -0.5% | -$3.13K | 0.01% | 382 |
|
|
2021
Q4 | $524K | Sell |
2,384
-960
| -29% | -$211K | ﹤0.01% | 415 |
|
|
2021
Q3 | $607K | Sell |
3,344
-14,188
| -81% | -$2.58M | 0.01% | 387 |
|
|
2021
Q2 | $3.54M | Sell |
17,532
-30
| -0.2% | -$6.05K | 0.03% | 179 |
|
|
2021
Q1 | $3.77M | Buy |
17,562
+4,609
| +36% | +$990K | 0.04% | 160 |
|
|
2020
Q4 | $3.06M | Buy |
12,953
+5,737
| +80% | +$1.36M | 0.03% | 160 |
|
|
2020
Q3 | $1.96M | Sell |
7,216
-544
| -7% | -$148K | 0.02% | 177 |
|
|
2020
Q2 | $2.25M | Buy |
7,760
+613
| +9% | +$178K | 0.03% | 159 |
|
|
2020
Q1 | $1.7M | Buy |
7,147
+1,841
| +35% | +$438K | 0.03% | 170 |
|
|
2019
Q4 | $1.16M | Buy |
+5,306
| New | +$1.16M | 0.02% | 240 |
|
|
2018
Q4 | – | Sell |
-46,397
| Closed | -$8.94M | – | 476 |
|
|
2018
Q3 | $8.94M | Buy |
46,397
+3,649
| +9% | +$703K | 0.12% | 95 |
|
|
2018
Q2 | $7.27M | Sell |
42,748
-21,554
| -34% | -$3.66M | 0.09% | 135 |
|
|
2018
Q1 | $10.5M | Sell |
64,302
-5,245
| -8% | -$855K | 0.13% | 109 |
|
|
2017
Q4 | $10.4M | Sell |
69,547
-15,965
| -19% | -$2.39M | 0.13% | 113 |
|
|
2017
Q3 | $13M | Buy |
85,512
+43,125
| +102% | +$6.56M | 0.17% | 100 |
|
|
2017
Q2 | $5.46M | Buy |
+42,387
| New | +$5.46M | 0.08% | 162 |
|